会員登録
ログイン
【4592】サンバイオ
再生細胞薬を開発。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.01 | 2024/09/17 | Q2予 | - | - | - | - | -3,339 | → | 0.0% | 0.0% | -3,359 | → | 0.0% | 0.0% | -3,359 | → | 0.0% | 0.0% |
| 2025.01 | 2024/06/13 | Q1予 | - | - | - | - | -3,339 | → | 0.0% | 0.0% | -3,359 | → | 0.0% | 0.0% | -3,359 | → | 0.0% | 0.0% |
| 2025.01 | 2024/03/18 | 当初予 | - | - | - | - | -3,339 | - | - | - | -3,359 | - | - | - | -3,359 | - | - | - |
| 2024.01 | 2024/03/18 | 実 | 0 | - | - | - | -4,539 | ↑ | +2.2% | +2.2% | -2,824 | ↑ | +38.6% | +38.6% | -2,644 | ↑ | +42.5% | +42.5% |
| 2024.01 | 2023/12/14 | Q3予 | - | - | - | - | -4,642 | → | 0.0% | 0.0% | -4,597 | → | 0.0% | 0.0% | -4,598 | → | 0.0% | 0.0% |
| 2024.01 | 2023/09/14 | Q2予 | - | - | - | - | -4,642 | → | 0.0% | 0.0% | -4,597 | → | 0.0% | 0.0% | -4,598 | → | 0.0% | 0.0% |
| 2024.01 | 2023/06/14 | Q1予 | - | - | - | - | -4,642 | → | 0.0% | 0.0% | -4,597 | → | 0.0% | 0.0% | -4,598 | → | 0.0% | 0.0% |
| 2024.01 | 2023/03/16 | 当初予 | - | - | - | - | -4,642 | - | - | - | -4,597 | - | - | - | -4,598 | - | - | - |
| 2023.01 | 2023/03/16 | 実 | 0 | - | - | - | -7,899 | ↑ | +2.9% | -34.8% | -4,698 | ↓ | -9.3% | +21.6% | -5,559 | ↑ | +2.2% | +7.3% |
| 2023.01 | 2022/12/15 | Q3予 | - | - | - | - | -8,131 | → | 0.0% | -38.8% | -4,298 | → | 0.0% | +28.3% | -5,684 | → | 0.0% | +5.2% |
| 2023.01 | 2022/09/14 | Q2予 | - | - | - | - | -8,131 | ↓ | -38.8% | -38.8% | -4,298 | ↑ | +28.3% | +28.3% | -5,684 | ↑ | +5.2% | +5.2% |
| 2023.01 | 2022/06/14 | Q1予 | - | - | - | - | -5,858 | → | 0.0% | 0.0% | -5,991 | → | 0.0% | 0.0% | -5,997 | → | 0.0% | 0.0% |
| 2023.01 | 2022/03/11 | 当初予 | - | - | - | - | -5,858 | - | - | - | -5,991 | - | - | - | -5,997 | - | - | - |
| 2022.01 | 2022/03/11 | 実 | 0 | - | - | - | -6,620 | ↓ | -14.4% | -14.4% | -4,579 | ↑ | +22.1% | +22.1% | -4,677 | ↑ | +20.4% | +20.4% |
| 2022.01 | 2021/12/15 | Q3予 | - | - | - | - | -5,786 | → | 0.0% | 0.0% | -5,876 | → | 0.0% | 0.0% | -5,877 | → | 0.0% | 0.0% |
| 2022.01 | 2021/09/14 | Q2予 | - | - | - | - | -5,786 | → | 0.0% | 0.0% | -5,876 | → | 0.0% | 0.0% | -5,877 | → | 0.0% | 0.0% |
| 2022.01 | 2021/06/14 | Q1予 | - | - | - | - | -5,786 | → | 0.0% | 0.0% | -5,876 | → | 0.0% | 0.0% | -5,877 | → | 0.0% | 0.0% |
| 2022.01 | 2021/03/17 | 当初予 | - | - | - | - | -5,786 | - | - | - | -5,876 | - | - | - | -5,877 | - | - | - |
| 2021.01 | 2021/03/17 | 実 | 0 | → | - | - | -5,801 | ↓ | -0.7% | -6.4% | -6,530 | ↓ | -0.6% | -17.8% | -3,385 | ↓ | -0.7% | +38.9% |
| 2021.01 | 2021/02/25 | 修正予 | 0 | - | - | - | -5,761 | ↓ | -5.6% | -5.6% | -6,490 | ↓ | -17.1% | -17.1% | -3,363 | ↑ | +39.3% | +39.3% |
| 2021.01 | 2020/12/15 | Q3予 | - | - | - | - | -5,453 | → | 0.0% | 0.0% | -5,543 | → | 0.0% | 0.0% | -5,544 | → | 0.0% | 0.0% |
| 2021.01 | 2020/09/14 | Q2予 | - | - | - | - | -5,453 | → | 0.0% | 0.0% | -5,543 | → | 0.0% | 0.0% | -5,544 | → | 0.0% | 0.0% |
| 2021.01 | 2020/06/12 | Q1予 | - | - | - | - | -5,453 | → | 0.0% | 0.0% | -5,543 | → | 0.0% | 0.0% | -5,544 | → | 0.0% | 0.0% |
| 2021.01 | 2020/03/16 | 当初予 | - | - | - | - | -5,453 | - | - | - | -5,543 | - | - | - | -5,544 | - | - | - |
| 2020.01 | 2020/03/16 | 実 | 447 | → | 0.0% | -37.3% | -5,486 | ↓ | -7.8% | +6.8% | -5,146 | ↓ | -11.5% | +4.5% | -5,157 | ↓ | -11.6% | +4.4% |
| 2020.01 | 2019/12/13 | 修正予 | 447 | ↓ | -37.3% | -37.3% | -5,088 | ↑ | +13.6% | +13.6% | -4,617 | ↑ | +14.3% | +14.3% | -4,619 | ↑ | +14.4% | +14.4% |
| 2020.01 | 2019/09/13 | Q2予 | 713 | → | 0.0% | 0.0% | -5,887 | → | 0.0% | 0.0% | -5,390 | → | 0.0% | 0.0% | -5,395 | → | 0.0% | 0.0% |
| 2020.01 | 2019/06/14 | Q1予 | 713 | → | 0.0% | 0.0% | -5,887 | → | 0.0% | 0.0% | -5,390 | → | 0.0% | 0.0% | -5,395 | → | 0.0% | 0.0% |
| 2020.01 | 2019/03/15 | 当初予 | 713 | - | - | - | -5,887 | - | - | - | -5,390 | - | - | - | -5,395 | - | - | - |
| 2019.01 | 2019/03/15 | 実 | 741 | ↓ | -0.1% | -27.7% | -3,733 | ↑ | +3.8% | -5.5% | -2,919 | ↑ | +1.8% | -15.4% | -2,920 | ↑ | +1.9% | -13.9% |
| 2019.01 | 2019/01/28 | 修正予 | 742 | ↓ | -27.6% | -27.6% | -3,881 | ↓ | -9.6% | -9.6% | -2,972 | ↓ | -17.5% | -17.5% | -2,978 | ↓ | -16.1% | -16.1% |
| 2019.01 | 2018/12/14 | Q3予 | 1,025 | → | 0.0% | 0.0% | -3,540 | → | 0.0% | 0.0% | -2,529 | → | 0.0% | 0.0% | -2,564 | → | 0.0% | 0.0% |
| 2019.01 | 2018/09/13 | Q2予 | 1,025 | → | 0.0% | 0.0% | -3,540 | → | 0.0% | 0.0% | -2,529 | → | 0.0% | 0.0% | -2,564 | → | 0.0% | 0.0% |
| 2019.01 | 2018/06/13 | Q1予 | 1,025 | → | 0.0% | 0.0% | -3,540 | → | 0.0% | 0.0% | -2,529 | → | 0.0% | 0.0% | -2,564 | → | 0.0% | 0.0% |
| 2019.01 | 2018/03/13 | 当初予 | 1,025 | - | - | - | -3,540 | - | - | - | -2,529 | - | - | - | -2,564 | - | - | - |
| 2018.01 | 2018/03/13 | 実 | 490 | ↓ | -26.0% | -26.0% | -4,378 | ↓ | -11.0% | -11.0% | -3,947 | ↑ | +0.3% | +0.3% | -3,940 | ↑ | +1.1% | +1.1% |
| 2018.01 | 2017/12/13 | Q3予 | 662 | → | 0.0% | 0.0% | -3,945 | → | 0.0% | 0.0% | -3,957 | → | 0.0% | 0.0% | -3,982 | → | 0.0% | 0.0% |
| 2018.01 | 2017/09/12 | Q2予 | 662 | → | 0.0% | 0.0% | -3,945 | → | 0.0% | 0.0% | -3,957 | → | 0.0% | 0.0% | -3,982 | → | 0.0% | 0.0% |
| 2018.01 | 2017/06/14 | Q1予 | 662 | → | 0.0% | 0.0% | -3,945 | → | 0.0% | 0.0% | -3,957 | → | 0.0% | 0.0% | -3,982 | → | 0.0% | 0.0% |
| 2018.01 | 2017/03/17 | 当初予 | 662 | - | - | - | -3,945 | - | - | - | -3,957 | - | - | - | -3,982 | - | - | - |
| 2017.01 | 2017/03/17 | 実 | 949 | ↑ | +0.2% | +7.1% | -1,932 | ↓ | -7.1% | +49.3% | -2,166 | ↑ | +5.9% | +43.4% | -1,835 | ↑ | +14.1% | +49.6% |
| 2017.01 | 2016/12/14 | Q3予 | 947 | ↑ | +6.9% | +6.9% | -1,804 | ↑ | +52.7% | +52.7% | -2,301 | ↑ | +39.9% | +39.9% | -2,136 | ↑ | +41.3% | +41.3% |
| 2017.01 | 2016/06/14 | Q1予 | 886 | → | 0.0% | 0.0% | -3,814 | → | 0.0% | 0.0% | -3,830 | → | 0.0% | 0.0% | -3,641 | → | 0.0% | 0.0% |
| 2017.01 | 2016/03/16 | 当初予 | 886 | - | - | - | -3,814 | - | - | - | -3,830 | - | - | - | -3,641 | - | - | - |
| 2016.01 | 2016/03/16 | 実 | 1,174 | → | 0.0% | -43.4% | -1,125 | → | 0.0% | -3.1% | -1,172 | → | 0.0% | -5.7% | -988 | → | 0.0% | -7.4% |
| 2016.01 | 2016/02/15 | 修正予 | 1,174 | ↓ | -36.0% | -43.4% | -1,125 | ↓ | -31.6% | -3.1% | -1,172 | ↓ | -39.9% | -5.7% | -988 | ↓ | -32.8% | -7.4% |
| 2016.01 | 2015/12/14 | Q3予 | 1,835 | → | 0.0% | -11.5% | -855 | → | 0.0% | +21.6% | -838 | ↑ | +2.0% | +24.4% | -744 | → | 0.0% | +19.1% |
| 2016.01 | 2015/09/14 | 修正予 | 1,835 | ↓ | -11.5% | -11.5% | -855 | ↑ | +21.6% | +21.6% | -855 | ↑ | +22.9% | +22.9% | -744 | ↑ | +19.1% | +19.1% |
| 2016.01 | 2015/06/12 | 当初予 | 2,074 | - | - | - | -1,091 | - | - | - | -1,109 | - | - | - | -920 | - | - | - |
